© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
ClearPoint Neuro, Inc. (CLPT) stock declined over -8.85%, trading at $11.64 on NASDAQ, down from the previous close of $12.77. The stock opened at $12.36, fluctuating between $11.60 and $12.56 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 15, 2026 | 12.36 | 12.56 | 11.61 | 11.64 | 725.71K |
| May 14, 2026 | 11.91 | 13.59 | 11.33 | 12.77 | 1.09M |
| May 13, 2026 | 12.59 | 12.78 | 11.99 | 12.19 | 780.23K |
| May 12, 2026 | 12.14 | 13.06 | 11.82 | 12.64 | 949.3K |
| May 11, 2026 | 12.64 | 12.89 | 11.99 | 12.31 | 570.23K |
| May 08, 2026 | 11.81 | 13.10 | 11.38 | 12.82 | 1.23M |
| May 07, 2026 | 11.37 | 12.02 | 11.37 | 11.68 | 363.93K |
| May 06, 2026 | 11.27 | 11.69 | 10.84 | 11.47 | 347.32K |
| May 05, 2026 | 11.31 | 11.35 | 10.71 | 11.10 | 299.68K |
| May 04, 2026 | 11.33 | 11.73 | 11.07 | 11.18 | 339.84K |
| Apr 30, 2026 | 10.35 | 11.28 | 10.26 | 11.18 | 489.1K |
| Apr 29, 2026 | 11.00 | 11.02 | 10.15 | 10.34 | 281.89K |
| Apr 28, 2026 | 11.15 | 11.43 | 10.90 | 11.08 | 277.64K |
| Apr 27, 2026 | 11.60 | 11.79 | 11.05 | 11.21 | 427.39K |
| Apr 23, 2026 | 11.02 | 11.04 | 10.43 | 10.75 | 325.93K |
| Apr 22, 2026 | 10.93 | 11.20 | 10.78 | 10.99 | 414.08K |
| Apr 21, 2026 | 11.25 | 11.37 | 10.64 | 10.72 | 407.67K |
| Apr 20, 2026 | 11.78 | 11.78 | 11.14 | 11.16 | 494.06K |
| Apr 17, 2026 | 10.75 | 11.82 | 10.60 | 11.79 | 599.17K |
| Apr 16, 2026 | 10.57 | 10.70 | 10.34 | 10.50 | 272.83K |
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
| Employees | 115 |
| Beta | 1.18 |
| Sales or Revenue | $23.96M |
| 5Y Sales Change% | 0.447% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Devices |